Neogen Corporation SEC filings document material events for an operating company focused on food safety and animal safety products. Recent 8-K filings cover quarterly results and financial condition, Regulation FD disclosures related to Petrifilm manufacturing validation, and exhibits containing earnings releases and business updates.
The company’s filings also record governance and leadership matters, including executive appointments and departures, compensatory arrangements, board committee assignments, annual meeting voting results, executive compensation votes, and auditor ratification. These disclosures provide formal records of Neogen’s public-company reporting, operating updates, governance structure and shareholder matters.
NEOGEN (NEOG) reported a routine insider equity event. A director acquired 1,777 shares of common stock on 10/27/2025 through the vesting and settlement of restricted stock units, reflected with transaction code M. The filing lists a price of $6.19 associated with the conversion. Following this transaction, the director beneficially owns 43,347 shares, held directly.
Neogen Corp (NEOG) disclosed a director transaction on a Form 4. On October 27, 2025, 1,777 restricted stock units vested and were settled for an equal number of common shares at a labeled price of $6.19 per share (Transaction Code M).
After the settlement, the director beneficially owned 19,117 shares, held directly. The filing notes that each RSU was the economic equivalent of one share of common stock, and these RSUs vested and were settled for the same number of shares on the stated date.
Neogen Corp (NEOG) insider activity: The company’s Chief Legal Officer reported the vesting and settlement of 9,474 restricted stock units into common stock on 10/27/2025, shown with transaction code M at a stated price of $6.19. A follow-on entry with code F reflects the disposition of 2,085 shares, typically for tax withholding, also at $6.19. After these transactions, the officer directly owned 57,240 shares.
The remarks clarify that each RSU equals one share of common stock and that the RSUs vested on October 27, 2025.
NEOGEN (NEOG) reported an insider transaction by its Chief Financial Officer. On October 27, 2025, 15,504 restricted stock units vested and were settled into the same number of common shares (code M) at $6.19. To cover taxes, 4,261 shares were withheld (code F) at $6.19. After these transactions, the officer directly owned 81,024 shares. Each RSU is equivalent to one share of common stock.
Neogen (NEOG) reported an insider equity event. On October 27, 2025, a former COO had 15,504 restricted stock units vest and convert to common stock (code M at $6.19 per unit). To cover taxes, 3,481 shares were withheld (code F at $6.19 per share). After these transactions, the insider beneficially owned 100,881 shares, held directly.
Each RSU was the economic equivalent of one share of common stock.
Neogen Corp (NEOG) insider filing: An officer (Former CEO) reported RSU vesting and related share movements. On October 27, 2025, 38,759 restricted stock units vested and were settled into an equal number of common shares at $6.19 per share (code M). A separate transaction disposed of 8,527 shares at $6.19 (code F).
Following these transactions, the reporting person beneficially owned 363,081 shares, held directly.
Neogen Corp (NEOG) director reported an RSU vesting on October 27, 2025: 3,553 shares of common stock were acquired via a code “M” conversion at $6.07 per share. Following the settlement, the reporting person beneficially owns 47,913 shares, held directly.
Each RSU equaled one share, and the RSUs vested and were settled for an equal number of shares on October 27, 2025.
Neogen Corporation filed an amended report to update information about a recent board appointment. The company previously disclosed that Avi Pelossof would join its Board of Directors effective October 24, 2025. This amendment adds details on his governance roles.
Neogen states that Mr. Pelossof has been appointed to serve on its Audit Committee and its Compensation and Talent Management Committee. The change clarifies his specific committee responsibilities, which were determined after the original report filed on August 14, 2025.
Neogen Corp (NEOG) reported a routine insider equity event. A director converted restricted stock units into common shares on 10/27/2025 (Transaction Code M). 2,025 shares of common stock were acquired at $6.19 per share upon RSU vesting and settlement. Following the transaction, the director beneficially owns 30,725 shares directly. The filing also lists 4,050 derivative securities (RSUs) beneficially owned after the reported transaction.
Neogen Corp (NEOG) reported an insider equity change by a director. On October 27, 2025, 2,025 restricted stock units vested and were settled into 2,025 shares of common stock (transaction code M) at a listed price of $6.19 per share. Following this settlement, the reporting person directly owned 94,570 shares.